Naveris, Inc. Employee Directory
Biotechnology ResearchMassachusetts, United States51-200 Employees
Naveris, Inc. is a biotechnology company focused on molecular diagnostics designed to improve the early detection and clinical management of viral-associated cancers. Its NavDx blood test targets tumor tissue modified viral DNA and is in use at leading cancer treatment centers and academic medical centers across the United States. The company is based in Waltham, Massachusetts, and operates within the biotechnology research industry. Its offerings are positioned to support oncology care by providing molecular residual disease detection and related insights for viral-induced cancers. In May 2026, reports indicate Naveris is developing blood-based tests to monitor for signs of organ transplant rejection.